Etid klinik pou Migrèn nan Arizona
10 etid pou Migrèn ap chèche patisipan nan sit nan Arizona.
Vil nan Arizona
Tèks ofisyèl etid la (Anglè)
Study of EVO756 in Adults With Migraine
- Trialsphere Corp, Chandler
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT07616128Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Perseverance Research Center, LLC, Scottsdale
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Perseverance Research Center, LLC, Scottsdale
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04649242Responding With Evidence and Access for Childhood Headaches
- Phoenix Children's Hospital - Barrow Neurological Institute, Phoenix
Ap rekrite
Laj 10 a 17 · Tout sèks · Mizajou Sep 21, 2026 · NCT05889624Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications
- Mayo Clinic in Arizona, Phoenix
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06401642Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Northern Arizona Healthcare, Flagstaff
- Mayo Clinic Arizona, Phoenix
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Sep 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Velocity Clinical Research - Phoenix /ID# 274478, Phoenix
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- TrialSphere, Chandler
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924Determining the Utility of a Behavioral Intervention in Chronic Migraine
- Mayo Clinic, Phoenix
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT05415020Light Exposure, Migraine Outcomes, and Sleep Quality
- ASU DeSmart Lab, Tempe
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 28, 2026 · NCT07476053Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.